Світлій пам'яті вченого-етнолога сучасності Ганни Горинь

Українське народознавство зазнало тяжкої втрати. Передчасно, напередодні Великодня (29 березня 2007 року), на 66 у році життя відійшла у вічність Ганна Йосипівна Горинь – відома вчена, етнолог, культуролог, кандидат історичних наук, старший науковий співробітник відділу етнології сучасності Інституту народознавства НАН України, член НТШ та вченої ради ІН НАНУ, талановитий педагог, кваліфікований музейний працівник із високим почуттям патріотичного обов’язку, громадянською свідомістю та національною гідністю.The article is dedicated to the memory of outstanding ethnographer, expert of culture, permanent worker of Modern Ethnology Department at the Institute of Ethnology of National Academy of Sciences of Ukraine Hanna Horyn. The life of this woman was full of many trials. Having overcome these trials she left rich scientific heritage

Quantifying the informational value of classification images

Reverse correlation is an influential psychophysical paradigm that uses a participant’s responses to randomly varying images to build a classification image (CI), which is commonly interpreted as a visualization of the participant’s mental representation. It is unclear, however, how to statistically quantify the amount of signal present in CIs, which limits the interpretability of these images. In this article, we propose a novel metric, infoVal, which assesses informational value relative to a resampled random distribution and can be interpreted like a z score. In the first part, we define the infoVal metric and show, through simulations, that it adheres to typical Type I error rates under various task conditions (internal validity). In the second part, we show that the metric correlates with markers of data quality in empirical reverse-correlation data, such as the subjective recognizability, objective discriminability, and test–retest reliability of the CIs (convergent validity). In the final part, we demonstrate how the infoVal metric can be used to compare the informational value of reverse-correlation datasets, by comparing data acquired online with data acquired in a controlled lab environment. We recommend a new standard of good practice in which researchers assess the infoVal scores of reverse-correlation data in order to ensure that they do not read signal in CIs where no signal is present. The infoVal metric is implemented in the open-source rcicr R package, to facilitate its adoption

FLAVOUR Study: FLow profiles And postoperative VasOplegia after continUous-flow left ventriculaR assist device implantation

Abstract: This study aims to associate the incidence of postoperative vasoplegia and short-term survival to the implantation of various left ventricular assist devices differing in hemocompatibility and flow profiles. The overall incidence of vasoplegia was 25.3% (73/289 patients) and 30.3% (37/122), 25.0% (18/72), and 18.9% (18/95) in the axial flow (AXF), centrifugal flow (CF), and centrifugal flow with artificial pulse (CFAP) group, respectively. Vasoplegia was associated with longer intensive care (ICU) and hospital length of stay (LOS) and mortality. ICU and in-hospital LOS and 1-year mortality were the lowest in the CFAP group. Post hoc analysis resulted in a p-value of 0.43 between AXF and CF; 0.35 between CF and CFAP; and 0.06 between AXF and CFAP. Although there is a trend in diminished incidence of vasoplegia, pooled logistic regression using flow profile and variables that remained after feature selection showed that flow profile was not an independent predictor for postoperative vasoplegia. Graphical Abstract: (Figure presented.

A meeting report: cross-cultural comparability of questionnaire measures in large-scale international surveys

The value of cross-country comparisons is at the heart of large-scale international surveys. Yet the validity of such comparisons is often challenged, particularly in the case of latent traits whose estimates are based on self-reported answers to a small number of questionnaire items. Many believe self-reports to be unreliable and not comparable, and indeed, formal statistical procedures very often reject the assumption that the questions are understood and answered in the same way in different countries (measurement invariance). A methodological conference on the comparability of questionnaire scales was hosted by the OECD on 8 and 9 November 2018. This meeting report summarises the discussions held at the conference about measurement invariance testing and instrument design. The report first provides a brief introduction to the measurement models and the accompanying invariance analyses typically used in the industry of large-scale international surveys and points to the main limitations of these current standard approaches. It then presents classical and novel ways to deal with imperfect comparability of measurements when scaling and reporting on continuous traits and on categorical latent variables. It finally discusses the extent to which item design can improve the cross-country comparability of the measured constructs (e.g. by adopting innovative item formats such as anchoring vignettes and situational judgement test items). It concludes with some general considerations for survey design and reporting on invariance analyses and survey results

Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.

PURPOSE: Total cell-free DNA (cfDNA) and tumor-derived cfDNA (ctDNA) can be used to study tumor-derived genetic aberrations. We analyzed the diagnostic and prognostic potential of cfDNA and ctDNA, obtained from pediatric patients with rhabdomyosarcoma. METHODS: cfDNA was isolated from diagnostic plasma samples from 57 patients enrolled in the EpSSG RMS2005 study. To study the diagnostic potential, shallow whole genome sequencing (shWGS) and cell-free reduced representation bisulphite sequencing (cfRRBS) were performed in a subset of samples and all samples were tested using droplet digital polymerase chain reaction to detect methylated RASSF1A (RASSF1A-M). Correlation with outcome was studied by combining cfDNA RASSF1A-M detection with analysis of our rhabdomyosarcoma-specific RNA panel in paired cellular blood and bone marrow fractions and survival analysis in 56 patients. RESULTS: At diagnosis, ctDNA was detected in 16 of 30 and 24 of 26 patients using shallow whole genome sequencing and cfRRBS, respectively. Furthermore, 21 of 25 samples were correctly classified as embryonal by cfRRBS. RASSF1A-M was detected in 21 of 57 patients. The presence of RASSF1A-M was significantly correlated with poor outcome (the 5-year event-free survival [EFS] rate was 46.2% for 21 RASSF1A-M‒positive patients, compared with 84.9% for 36 RASSF1A-M‒negative patients [P < .001]). RASSF1A-M positivity had the highest prognostic effect among patients with metastatic disease. Patients both negative for RASSF1A-M and the rhabdomyosarcoma-specific RNA panel (28 of 56 patients) had excellent outcome (5-year EFS 92.9%), while double-positive patients (11/56) had poor outcome (5-year EFS 13.6%, P < .001). CONCLUSION: Analyzing ctDNA at diagnosis using various techniques is feasible in pediatric rhabdomyosarcoma and has potential for clinical use. Measuring RASSF1A-M in plasma at initial diagnosis correlated significantly with outcome, particularly when combined with paired analysis of blood and bone marrow using a rhabdomyosarcoma-specific RNA panel

Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia

Fetal neonatal alloimmune thrombocytopenia (FNAIT) is caused by maternal alloantibodies directed against the human platelet antigens (mostly HPA-1a or HPA-5b) of the (unborn) child and can lead to severe bleeding. Anti-HPA-1a-mediated FNAIT shows a severe clinical outcome more often than anti-HPA-5b-mediated FNAIT. Given the relatively high prevalence of anti-HPA-5b in pregnant women, the detection of anti-HPA-5b in FNAIT-suspected cases may in some cases be an incidental finding. Therefore we investigated the frequency of anti-HPA-5b-associated severe bleeding in FNAIT. We performed a retrospective nationwide cohort study in cases with clinical suspicion of FNAIT. HPA antibody screening was performed using monoclonal antibody-specific immobilisation of platelet antigens. Parents and neonates were typed for the cognate antigen. Clinical data were collected by a structured questionnaire. In 1 864 suspected FNAIT cases, 161 cases (8 center dot 6%) had anti-HPA-1a and 60 (3 center dot 2%) had anti-HPA-5b. The proportion of cases with severe bleeding did not differ between the cases with anti-HPA-1a (14/129; 11%) and anti-HPA-5b (4/40; 10%). In multigravida pregnant women with a FNAIT-suspected child, 100% (81/81) of anti-HPA-1a cases and 79% (38/48) of anti-HPA-5b cases were HPA-incompatible, whereas 86% and 52% respectively were expected, based on the HPA allele distribution. We conclude that anti-HPA-5b can be associated with severe neonatal bleeding symptoms. A prospective study is needed for true assessment of the natural history of anti-HPA-5b mediated FNAIT.Developmen

Performance of active learning models for screening prioritization in systematic reviews: a simulation study into the Average Time to Discover relevant records

Background: Conducting a systematic review demands a significant amount of effort in screening titles and abstracts. To accelerate this process, various tools that utilize active learning have been proposed. These tools allow the reviewer to interact with machine learning software to identify relevant publications as early as possible. The goal of this study is to gain a comprehensive understanding of active learning models for reducing the workload in systematic reviews through a simulation study. Methods: The simulation study mimics the process of a human reviewer screening records while interacting with an active learning model. Different active learning models were compared based on four classification techniques (naive Bayes, logistic regression, support vector machines, and random forest) and two feature extraction strategies (TF-IDF and doc2vec). The performance of the models was compared for six systematic review datasets from different research areas. The evaluation of the models was based on the Work Saved over Sampling (WSS) and recall. Additionally, this study introduces two new statistics, Time to Discovery (TD) and Average Time to Discovery (ATD). Results: The models reduce the number of publications needed to screen by 91.7 to 63.9% while still finding 95% of all relevant records (WSS@95). Recall of the models was defined as the proportion of relevant records found after screening 10% of of all records and ranges from 53.6 to 99.8%. The ATD values range from 1.4% till 11.7%, which indicate the average proportion of labeling decisions the researcher needs to make to detect a relevant record. The ATD values display a similar ranking across the simulations as the recall and WSS values. Conclusions: Active learning models for screening prioritization demonstrate significant potential for reducing the workload in systematic reviews. The Naive Bayes + TF-IDF model yielded the best results overall. The Average Time to Discovery (ATD) measures performance of active learning models throughout the entire screening process without the need for an arbitrary cut-off point. This makes the ATD a promising metric for comparing the performance of different models across different datasets

Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273

BACKGROUND: Patients affected by different types of autoimmune diseases, including common conditions such as multiple sclerosis (MS) and rheumatoid arthritis (RA), are often treated with immunosuppressants to suppress disease activity. It is not fully understood how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific humoral and cellular immunity induced by infection and/or upon vaccination is affected by immunosuppressants. METHODS: The dynamics of cellular immune reactivation upon vaccination of SARS-CoV-2 experienced MS patients treated with the humanized anti-CD20 monoclonal antibody ocrelizumab (OCR) and RA patients treated with methotrexate (MTX) monotherapy were analyzed at great depth via high-dimensional flow cytometry of whole blood samples upon vaccination with the SARS-CoV-2 mRNA-1273 (Moderna) vaccine. Longitudinal B and T cell immune responses were compared to SARS-CoV-2 experienced healthy controls (HCs) before and 7 days after the first and second vaccination. RESULTS: OCR-treated MS patients exhibit a preserved recall response of CD8(+) T central memory cells following first vaccination compared to HCs and a similar CD4(+) circulating T follicular helper 1 and T helper 1 dynamics, whereas humoral and B cell responses were strongly impaired resulting in absence of SARS-CoV-2-specific humoral immunity. MTX treatment significantly delayed antibody levels and B reactivation following the first vaccination, including sustained inhibition of overall reactivation marker dynamics of the responding CD4(+) and CD8(+) T cells. CONCLUSIONS: Together, these findings indicate that SARS-CoV-2 experienced MS-OCR patients may still benefit from vaccination by inducing a broad CD8(+) T cell response which has been associated with milder disease outcome. The delayed vaccine-induced IgG kinetics in RA-MTX patients indicate an increased risk after the first vaccination, which might require additional shielding or alternative strategies such as treatment interruptions in vulnerable patients. FUNDING: This research project was supported by ZonMw (The Netherlands Organization for Health Research and Development, #10430072010007), the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement (#792532 and #860003), the European Commission (SUPPORT-E, #101015756) and by PPOC (#20_21 L2506), the NHMRC Leadership Investigator Grant (#1173871)

T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis

Purpose: Currently, markers are lacking that can identify patients with high risk nonmuscle invasive bladder cancer who will fail bacillus Calmette-Guérin treatment. Therefore, we evaluated the prognostic value of T1 substaging in patients with primary high risk nonmuscle invasive bladder cancer. Materials and Methods: Patients with primary high risk nonmuscle invasive bladder cancer who received ≥5 bacillus Calmette-Guérin induction instillations were included. All tumors were centrally reviewed, which included T1 substaging (microinvasion vs extensive invasion of the lamina propria). T1 patients were stratified into high risk or highest risk subgroups according to major urology guidelines. Primary end point was bacillus Calmette-Guérin failure, defined as development of a high grade recurrence. Secondary end points were high grade recurrence-free survival, defined as time from primary diagnosis to biopsy-proven high grade recurrence and progression-free survival. Time-to-event analyses were used to predict survival. Results: A total of 264 patients with high risk nonmuscle invasive bladder cancer had tumor invasion of the lamina propria, of which 73% were classified as extensive invasion and 27% as microinvasion. Median followup was 68 months (IQR 43–98) and bacillus Calmette-Guérin failure was more common among patients with extensive vs microinvasive tumors (41% vs 21%, p=0.002). The 3-year high grade recurrence-free survival (defined as bacillus Calmette-Guerin failure) for patients with extensive vs microinvasive tumors was 64% vs 83% (p=0.004). In multivariate analysis, T1 substaging was an independent predictor of high grade recurrence-free survival (HR 3.2, p=0.005) and progression-free survival (HR 3.0, p=0.009). Patients with highest risk/microinvasive disease have an improved progression-free survival as compared to highest risk/T1e disease (p.adj=0.038). Conclusions: T1 substaging provides important prognostic information on patients with primary high risk nonmuscle invasive bladder cancer treated with bacillus Calmette-Guérin. The risk of bacillus Calmette-Guérin failure is higher in extensive vs microinvasive tumors. Substaging of T1 high risk nonmuscle invasive bladder cancer has the potential to guide treatment decisions on bacillus Calmette-Guérin vs alternative strategies at diagnosis.publishedVersio